stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Return on equity
STERIS plc's return on equity over the twelve months to 30 September 2026 was 11.6%, up 0.2 percentage points from fiscal 2026 (11.3%). Over the past ten years it has ranged from 1.69% (fiscal 2023) to 12.8% (fiscal 2015); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of −10.4% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 11.3% | 1.82 |
| FY2025 | 9.51% | 3.41 |
| FY2024 | 6.10% | 4.41 |
| FY2023 | 1.69% | (2.98) |
| FY2022 | 4.67% | (6.20) |
| FY2021 | 10.9% | (1.48) |
| FY2020 | 12.4% | 2.86 |
| FY2019 | 9.49% | (0.16) |
| FY2018 | 9.65% | 5.89 |
| FY2017 | 3.76% | (1.63) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 37.7% |
| GEHC GE HealthCare Technologies Inc. compare | 19.9% |
| GMED Globus Medical, Inc. compare | 12.1% |
| STE STERIS plc | 11.6% |
| PEN Penumbra, Inc. compare | 10.7% |
| PHG Koninklijke Philips N.V. compare | 8.54% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.02% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| GKOS Glaukos Corporation compare | −22.8% |
| Medical Devices industry median | −10.4% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement